Report Thumbnail
Product Code LP0911816527TZ
Published Date 2026/7/4
English122 PagesGlobal

Global 293 Cell Culture Medium Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market


Report Thumbnail
Product Code LP0911816527TZ
Published Date 2026/7/4
English 122 PagesGlobal

Global 293 Cell Culture Medium Market Growth 2026-2032 ‐ Pharmaceutical / LifeSciense Market



Abstract

This comprehensive report provides a detailed analysis of the global 293 Cell Culture Medium market, projecting its growth trajectory through 2032. The study examines key market dynamics, segmentation by type and application, and regional trends across the Americas, APAC, and Europe. By evaluating leading players such as Lonza and Sartorius AG, the research highlights competitive strategies, emerging opportunities in vaccine production and biotechnology research, and the technological factors driving the industry's accelerating global expansion.

Related Questions

Lonza, Sartorius AG, Capricorn Scientific, Shanghai BioEngine Sci-Tech Co., Ltd, Sino Biological, OPM Biosciences, Creative Bioarray, FUJIFILM Irvine Scientific, Thermo Fisher Scientific, Synthego, Irvine Scientific, Florabio, Beckman Coulter, Inc., R&D Systems, Tofflon Life Science


Summary

Executive Overview

Global Market Outlook

The global 293 Cell Culture Medium market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Regional Market Projections

  • United States: The market for 293 Cell Culture Medium in the United States is estimated to increase from 2025 through 2032, maintaining a consistent growth trajectory.
  • China: The market for 293 Cell Culture Medium in China is estimated to undergo expansion between 2025 and 2032.
  • Europe: The European market for 293 Cell Culture Medium is expected to see an increase in value from 2025 to 2032.

About the Report

Produced by LP Information, Inc. (LPI), the “293 Cell Culture Medium Industry Forecast” reviews total global sales for 2025 and provides a comprehensive analysis of projected sales for the period of 2026 through 2032. The report offers a detailed analysis in US$ millions, with sales broken down by region, market sector, and sub-sector.

This Insight Report provides a comprehensive analysis of the global 293 Cell Culture Medium landscape, highlighting key trends related to:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on their 293 Cell Culture Medium portfolios and capabilities, market entry strategies, market positions, and geographic footprints to better understand their unique positions in an accelerating global market.

Methodology and Scope

The report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Application, geography, and market size to highlight emerging pockets of opportunity. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study offers a highly nuanced view of the current state and future trajectory of the global 293 Cell Culture Medium industry.

Market Segmentation

By Type

  • Liquid 293 Cell Culture Medium
  • Dry Powder 293 Cell Culture Medium

By Application

  • Recombinant Protein Expression
  • Virus Packaging
  • Vaccine Production
  • High-density Cell Culture
  • Biotechnology Research
  • Others

By Region

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Competitive Landscape

Key Market Dynamics

Global key 293 Cell Culture Medium players include Lonza, Sartorius AG, Capricorn Scientific, Shanghai BioEngine Sci-Tech Co., Ltd, and Sino Biological. In terms of revenue, the global two largest companies held a significant portion of the market share in 2025.

Profiled Companies

The following companies have been profiled based on inputs from primary experts and analysis of their coverage, product portfolio, and market penetration:

  • Lonza
  • Sartorius AG
  • Capricorn Scientific
  • Shanghai BioEngine Sci-Tech Co., Ltd
  • Sino Biological
  • OPM Biosciences
  • Creative Bioarray
  • FUJIFILM Irvine Scientific
  • Thermo Fisher Scientific
  • Synthego
  • Irvine Scientific
  • Florabio
  • Beckman Coulter, Inc.
  • R&D Systems
  • Tofflon Life Science

Key Questions Addressed

  • What is the 10-year outlook for the global 293 Cell Culture Medium market?
  • What factors are driving 293 Cell Culture Medium market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do 293 Cell Culture Medium market opportunities vary by end market size?
  • How does 293 Cell Culture Medium break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global 293 Cell Culture Medium Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for 293 Cell Culture Medium by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for 293 Cell Culture Medium by Country/Region, 2021, 2025 & 2032
    • 2.2 293 Cell Culture Medium Segment by Type
      • 2.2.1 Liquid 293 Cell Culture Medium
      • 2.2.2 Dry Powder 293 Cell Culture Medium
      • 2.2.3 293 Cell Culture Medium Sales by Type
        • 2.2.3.1 Global 293 Cell Culture Medium Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global 293 Cell Culture Medium Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global 293 Cell Culture Medium Sale Price by Type (2021-2026)
    • 2.3 293 Cell Culture Medium Segment by Application
      • 2.3.1 Recombinant Protein Expression
      • 2.3.2 Virus Packaging
      • 2.3.3 Vaccine Production
      • 2.3.4 High-density Cell Culture
      • 2.3.5 Biotechnology Research
      • 2.3.6 Others
      • 2.3.7 293 Cell Culture Medium Sales by Application
        • 2.3.7.1 Global 293 Cell Culture Medium Sale Market Share by Application (2021-2026)
        • 2.3.7.2 Global 293 Cell Culture Medium Revenue and Market Share by Application (2021-2026)
        • 2.3.7.3 Global 293 Cell Culture Medium Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global 293 Cell Culture Medium Breakdown Data by Company
      • 3.1.1 Global 293 Cell Culture Medium Annual Sales by Company (2021-2026)
      • 3.1.2 Global 293 Cell Culture Medium Sales Market Share by Company (2021-2026)
    • 3.2 Global 293 Cell Culture Medium Annual Revenue by Company (2021-2026)
      • 3.2.1 Global 293 Cell Culture Medium Revenue by Company (2021-2026)
      • 3.2.2 Global 293 Cell Culture Medium Revenue Market Share by Company (2021-2026)
    • 3.3 Global 293 Cell Culture Medium Sale Price by Company
    • 3.4 Key Manufacturers 293 Cell Culture Medium Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers 293 Cell Culture Medium Product Location Distribution
      • 3.4.2 Players 293 Cell Culture Medium Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for 293 Cell Culture Medium by Geographic Region

    • 4.1 World Historic 293 Cell Culture Medium Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global 293 Cell Culture Medium Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global 293 Cell Culture Medium Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic 293 Cell Culture Medium Market Size by Country/Region (2021-2026)
      • 4.2.1 Global 293 Cell Culture Medium Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global 293 Cell Culture Medium Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas 293 Cell Culture Medium Sales Growth
    • 4.4 APAC 293 Cell Culture Medium Sales Growth
    • 4.5 Europe 293 Cell Culture Medium Sales Growth
    • 4.6 Middle East & Africa 293 Cell Culture Medium Sales Growth
  • 5 Americas

    • 5.1 Americas 293 Cell Culture Medium Sales by Country
      • 5.1.1 Americas 293 Cell Culture Medium Sales by Country (2021-2026)
      • 5.1.2 Americas 293 Cell Culture Medium Revenue by Country (2021-2026)
    • 5.2 Americas 293 Cell Culture Medium Sales by Type (2021-2026)
    • 5.3 Americas 293 Cell Culture Medium Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC 293 Cell Culture Medium Sales by Region
      • 6.1.1 APAC 293 Cell Culture Medium Sales by Region (2021-2026)
      • 6.1.2 APAC 293 Cell Culture Medium Revenue by Region (2021-2026)
    • 6.2 APAC 293 Cell Culture Medium Sales by Type (2021-2026)
    • 6.3 APAC 293 Cell Culture Medium Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe 293 Cell Culture Medium by Country
      • 7.1.1 Europe 293 Cell Culture Medium Sales by Country (2021-2026)
      • 7.1.2 Europe 293 Cell Culture Medium Revenue by Country (2021-2026)
    • 7.2 Europe 293 Cell Culture Medium Sales by Type (2021-2026)
    • 7.3 Europe 293 Cell Culture Medium Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa 293 Cell Culture Medium by Country
      • 8.1.1 Middle East & Africa 293 Cell Culture Medium Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa 293 Cell Culture Medium Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa 293 Cell Culture Medium Sales by Type (2021-2026)
    • 8.3 Middle East & Africa 293 Cell Culture Medium Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of 293 Cell Culture Medium
    • 10.3 Manufacturing Process Analysis of 293 Cell Culture Medium
    • 10.4 Industry Chain Structure of 293 Cell Culture Medium
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 293 Cell Culture Medium Distributors
    • 11.3 293 Cell Culture Medium Customer
  • 12 World Forecast Review for 293 Cell Culture Medium by Geographic Region

    • 12.1 Global 293 Cell Culture Medium Market Size Forecast by Region
      • 12.1.1 Global 293 Cell Culture Medium Forecast by Region (2027-2032)
      • 12.1.2 Global 293 Cell Culture Medium Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global 293 Cell Culture Medium Forecast by Type (2027-2032)
    • 12.7 Global 293 Cell Culture Medium Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Lonza
      • 13.1.1 Lonza Company Information
      • 13.1.2 Lonza 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.1.3 Lonza 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Lonza Main Business Overview
      • 13.1.5 Lonza Latest Developments
    • 13.2 Sartorius AG
      • 13.2.1 Sartorius AG Company Information
      • 13.2.2 Sartorius AG 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.2.3 Sartorius AG 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 Sartorius AG Main Business Overview
      • 13.2.5 Sartorius AG Latest Developments
    • 13.3 Capricorn Scientific
      • 13.3.1 Capricorn Scientific Company Information
      • 13.3.2 Capricorn Scientific 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.3.3 Capricorn Scientific 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 Capricorn Scientific Main Business Overview
      • 13.3.5 Capricorn Scientific Latest Developments
    • 13.4 Shanghai BioEngine Sci-Tech Co., Ltd
      • 13.4.1 Shanghai BioEngine Sci-Tech Co., Ltd Company Information
      • 13.4.2 Shanghai BioEngine Sci-Tech Co., Ltd 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.4.3 Shanghai BioEngine Sci-Tech Co., Ltd 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Shanghai BioEngine Sci-Tech Co., Ltd Main Business Overview
      • 13.4.5 Shanghai BioEngine Sci-Tech Co., Ltd Latest Developments
    • 13.5 Sino Biological
      • 13.5.1 Sino Biological Company Information
      • 13.5.2 Sino Biological 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.5.3 Sino Biological 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.5.4 Sino Biological Main Business Overview
      • 13.5.5 Sino Biological Latest Developments
    • 13.6 OPM Biosciences
      • 13.6.1 OPM Biosciences Company Information
      • 13.6.2 OPM Biosciences 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.6.3 OPM Biosciences 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.6.4 OPM Biosciences Main Business Overview
      • 13.6.5 OPM Biosciences Latest Developments
    • 13.7 Creative Bioarray
      • 13.7.1 Creative Bioarray Company Information
      • 13.7.2 Creative Bioarray 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.7.3 Creative Bioarray 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.7.4 Creative Bioarray Main Business Overview
      • 13.7.5 Creative Bioarray Latest Developments
    • 13.8 FUJIFILM Irvine Scientific
      • 13.8.1 FUJIFILM Irvine Scientific Company Information
      • 13.8.2 FUJIFILM Irvine Scientific 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.8.3 FUJIFILM Irvine Scientific 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.8.4 FUJIFILM Irvine Scientific Main Business Overview
      • 13.8.5 FUJIFILM Irvine Scientific Latest Developments
    • 13.9 Thermo Fisher Scientific
      • 13.9.1 Thermo Fisher Scientific Company Information
      • 13.9.2 Thermo Fisher Scientific 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.9.3 Thermo Fisher Scientific 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.9.4 Thermo Fisher Scientific Main Business Overview
      • 13.9.5 Thermo Fisher Scientific Latest Developments
    • 13.10 Synthego
      • 13.10.1 Synthego Company Information
      • 13.10.2 Synthego 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.10.3 Synthego 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.10.4 Synthego Main Business Overview
      • 13.10.5 Synthego Latest Developments
    • 13.11 Irvine Scientific
      • 13.11.1 Irvine Scientific Company Information
      • 13.11.2 Irvine Scientific 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.11.3 Irvine Scientific 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.11.4 Irvine Scientific Main Business Overview
      • 13.11.5 Irvine Scientific Latest Developments
    • 13.12 Florabio
      • 13.12.1 Florabio Company Information
      • 13.12.2 Florabio 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.12.3 Florabio 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.12.4 Florabio Main Business Overview
      • 13.12.5 Florabio Latest Developments
    • 13.13 Beckman Coulter, Inc.
      • 13.13.1 Beckman Coulter, Inc. Company Information
      • 13.13.2 Beckman Coulter, Inc. 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.13.3 Beckman Coulter, Inc. 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.13.4 Beckman Coulter, Inc. Main Business Overview
      • 13.13.5 Beckman Coulter, Inc. Latest Developments
    • 13.14 R&D Systems
      • 13.14.1 R&D Systems Company Information
      • 13.14.2 R&D Systems 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.14.3 R&D Systems 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.14.4 R&D Systems Main Business Overview
      • 13.14.5 R&D Systems Latest Developments
    • 13.15 Tofflon Life Science
      • 13.15.1 Tofflon Life Science Company Information
      • 13.15.2 Tofflon Life Science 293 Cell Culture Medium Product Portfolios and Specifications
      • 13.15.3 Tofflon Life Science 293 Cell Culture Medium Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.15.4 Tofflon Life Science Main Business Overview
      • 13.15.5 Tofflon Life Science Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.